Delivery Order SPE2DS23D0001-SPE2D625F3BCU
- Not listed
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Meditrade Medical Trading GMBH, a for-profit limited liability company based in Oyten, Germany. The contract is for the supply of 4,567,931,218 units of "DENGUE DUO NS1 25S" diagnostic test kits, with a ceiling value of $1,083.74. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 18, 2025. Meditrade GMBH is an active federal contractor that...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $12,620.40 to Meditrade Medical Trading GMBH, a Germany-based medical supplies vendor, on August 8, 2025. The delivery order, designated 4569028259, covers SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic test kits with a completion date of August 12, 2025. This firm fixed-price contract was awarded without set-aside designation, reflecting Meditrade's ability to compete in the open...
- This federal contract award, valued at $1,225.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Meditrade Medical Trading GMBH, a for-profit limited liability company based in Germany. The contract is a Delivery Order under a larger $2.88 million Indefinite Delivery Contract (SPE2DS23D0001) with DLA Troop Support Medical, effective through January 2028. The contract is for the procurement of "DENGUE DUO NS1 25S", which are medical supplies and diagnostic...
- The U.S. Department of Defense Medical Supply Chain has awarded a delivery order valued at $5,048.19 to Meditrade Medical Trading GMBH, a Germany-based medical supplies vendor, for SARS-CoV-2, influenza, and respiratory syncytial virus diagnostic test kits. The contract, issued on August 15, 2025, with an ultimate completion date of August 19, 2025, operates under a firm fixed-price arrangement with no set-aside designation. Meditrade GMBH will perform the work at its location in Germany and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,030.40 to Meditrade Medical Trading GMBH, a Germany-based medical supplies vendor, on September 9, 2025. The contract calls for the delivery of D-Dimer Triage test kits—diagnostic tools used for rapid assessment in clinical settings—with a completion date of September 11, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete in the open federal market. The...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $12,620.43 to Meditrade Medical Trading GMBH on August 29, 2025, for the supply of SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic test kits. The contract carries a firm fixed price structure with no set-aside designation, allowing the vendor to compete in the open federal market. Performance is scheduled for completion by September 2, 2025, with work to be performed in Germany. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,060.07 to Meditrade Medical Trading GMBH, a Germany-based medical supplies vendor, on September 2, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was awarded without set-aside designation, allowing the contractor to compete in the open federal market. Meditrade GMBH, based in Oyten, Germany, will perform the work at its location in Germany and...
- The U.S. Department of Defense's Medical Supply Chain awarded a firm fixed-price delivery order valued at $11,989.34 to Meditrade Medical Trading GMBH for SARS-CoV-2, influenza, and respiratory syncytial virus diagnostic test kits. The contract was awarded on July 23, 2025, with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Meditrade GMBH, a Germany-based medical supply company with a Universal Entity Identifier (UEI) of FZF7KMCH21Q8, will perform the work...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Meditrade Medical Trading GMBH, a for-profit limited liability company based in Germany. The $2,612.33 firm fixed-price delivery order is for the supply of medical diagnostic test kits, including those for SARS-CoV-2, influenza, respiratory syncytial virus, and dengue. The contract has an ultimate completion date of July 11, 2025 and does not have a set-aside designation. Meditrade GMBH is an...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,859.34 to Meditrade Medical Trading GMBH, a Germany-based medical supplies contractor, on July 28, 2025, with an ultimate completion date of July 30, 2025. The contract covers the delivery of test determination HBSAG 2 20S materials and is structured as a firm fixed-price delivery order with no set-aside designation, allowing the contractor to compete in the open federal market. Performance will take place...
- SPE2DS23D0001Indefinite Delivery Contract
- SPE2DS23D0001-SPE2D625F3BCUDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain organization awarded a $2,640.40 firm fixed-price delivery order to Meditrade Medical Trading GMBH, a Germany-based medical supplies contractor, on September 11, 2025. The delivery order, identified as DENGUE DUO NS1 25S, calls for the supply of dengue diagnostic test kits and is scheduled for completion by September 15, 2025. This award was made without a set-aside designation, allowing Meditrade to compete directly in the open federal market. The place of performance is Germany, where Meditrade maintains its headquarters in Oyten. Meditrade Medical Trading GMBH has been an active federal contractor since 2004 and specializes in providing diagnostic test kits, laboratory reagents, and medical supplies to support U.S. military healthcare operations. This delivery order is likely issued under one of the company's two significant $2 million Blanket Purchase Agreements with the U.S. Army Medical Command, which extend through June 29, 2026, and are designed to supply laboratory and medical commodities to support U.S. military personnel stationed overseas. The contractor's track record demonstrates consistent capability in delivering diagnostic testing solutions, including products for SARS-CoV-2, influenza, respiratory syncytial virus, and dengue, making it well-positioned to support pandemic preparedness and disease surveillance requirements for U.S. defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/11/25 |